Evidence map›Paper›PMID 33465062›Full record

ArticlePLoS genetics2021

Htt is a repressor of Abl activity required for APP-induced axonal growth.

Claire Marquilly, Germain U Busto, Brittany S Leger, Ana Boulanger, Edward Giniger, James A Walker, Lee G Fradkin, Jean-Maurice Dura

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Frontiers in neuroscience · 2023
    Review
  8. The making of the Drosophila mushroom body.Frontiers in physiology · 2023
    Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Claire MarquillyIGH, Centre National de la Recherche Scientifique, Univ Montpellier, Montpellier, France.ORCID 0000-0003-1795-2860
Germain U BustoIGH, Centre National de la Recherche Scientifique, Univ Montpellier, Montpellier, France.ORCID 0000-0002-8787-563X
Brittany S LegerCenter for Genomic Medicine, Massachusetts General Hospital, Boston, Massachusetts, United States of America.ORCID 0000-0002-8467-5472
Ana BoulangerIGH, Centre National de la Recherche Scientifique, Univ Montpellier, Montpellier, France.
Edward GinigerIntramural Research Program, NINDS, NIH, Bethesda, Maryland, United States of America.ORCID 0000-0002-8340-6158
James A WalkerCenter for Genomic Medicine, Massachusetts General Hospital, Boston, Massachusetts, United States of America.ORCID 0000-0001-5585-698X
Lee G FradkinDepartment of Neurobiology, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America.ORCID 0000-0002-5282-2984
Jean-Maurice DuraIGH, Centre National de la Recherche Scientifique, Univ Montpellier, Montpellier, France.ORCID 0000-0001-8296-9023
Université de Montpellier · FRBroad Institute · USMassachusetts General Hospital · USOffice of Extramural Research · USUniversity of Massachusetts Chan Medical School · US

Funding

Mechanisms of axon guidance during developmentZIANS003013 · NINDS · NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE · PI GINIGER, EDWARD · 2009 to 2025
$17.2M
Roles of Cdk5 in neurodevelopment and neurodegenerationZIANS003106 · NINDS · NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE · PI GINIGER, EDWARD · 2009 to 2025
$17.0M
Mechanisms of axon guidance during developmentZ01NS003013 · NINDS · NEUROLOGICAL DISORDERS AND STROKE · PI GINIGER, EDWARD · 2005 to 2008
$2.0M
Intramural NIH HHS Z01 NS003013
6 · The paper itself

Abstract

Huntington's disease is a progressive autosomal dominant neurodegenerative disorder caused by the expansion of a polyglutamine tract at the N-terminus of a large cytoplasmic protein. The Drosophila huntingtin (htt) gene is widely expressed during all developmental stages from embryos to adults. However, Drosophila htt mutant individuals are viable with no obvious developmental defects. We asked if such defects could be detected in htt mutants in a background that had been genetically sensitized to reveal cryptic developmental functions. Amyloid precursor protein (APP) is linked to Alzheimer's disease. Appl is the Drosophila APP ortholog and Appl signaling modulates axon outgrowth in the mushroom bodies (MBs), the learning and memory center in the fly, in part by recruiting Abl tyrosine kinase. Here, we find that htt mutations suppress axon outgrowth defects of αβ neurons in Appl mutant MB by derepressing the activity of Abl. We show that Abl is required in MB αβ neurons for their axon outgrowth. Importantly, both Abl overexpression and lack of expression produce similar phenotypes in the MBs, indicating the necessity of tightly regulating Abl activity. We find that Htt behaves genetically as a repressor of Abl activity, and consistent with this, in vivo FRET-based measurements reveal a significant increase in Abl kinase activity in the MBs when Htt levels are reduced. Thus, Appl and Htt have essential but opposing roles in MB development, promoting and suppressing Abl kinase activity, respectively, to maintain the appropriate intermediate level necessary for axon growth.

Indexed as

AcyltransferasesAlzheimer DiseaseAmyloid beta-Protein PrecursorAnimalsAxonal TransportAxonsDrosophila melanogasterDrosophila ProteinsEmbryonic DevelopmentHumansHuntingtin ProteinHuntington DiseaseLearningMemoryMushroom BodiesMutationAcyltransferasesAmyloid beta-Protein PrecursorApp protein, DrosophilaDrosophila ProteinsHtt protein, DrosophilaHTT protein, humanHuntingtin Protein

Identifiers

PMID33465062
PMCPMC7845969
OpenAlexW3121194064

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.